|
Immunization Safety Review Committee
Meeting 9: Vaccines and Autism
The National Academy of Sciences, Auditorium
2100 C Street NW,
Washington, DC 20418
February 9, 2004
Agenda
PLEASE NOTE:
Online presentations from the Vaccines and Autism meeting are subject to copyright protection.
Permission from the speaker is required prior to any copying, reproducing, or rebroadcasting any portion of the speaker's presentations.
Additional copyright and legal policies of The National Academies can be read here.
THE AUDIOFILES OF THE IOM IMMUNIZATION SAFETY REVIEW MEETING ON VACCINES AND AUTISM ON FEBRUARY 9, 2004 AND THE INFORMATION CONTAINED THEREIN IS NOT AN OFFICIAL REPORT OF THE INSTITUTE OF MEDICINE OR THE NATIONAL ACADEMY OF SCIENCES ("NATIONAL ACADEMIES"), AND THE OPINIONS AND THE STATEMENTS INCLUDED IN THE AUDIOFILES ARE SOLELY THOSE OF THE INDIVIDUAL PARTICIPANTS AS RECORDED BY THE NATIONAL ACADEMIES, AND ARE NOT ADOPTED OR ENDORSED OR VERIFIED AS ACCURATE.
Internet Explorer is recommended for viewing the slides.
Some presentations may not be accessible with Netscape Navigator.
The presentations are available as PDF files which require Adobe Acrobat Reader.
Click here to download Adobe Acrobat Reader for free.
Available Presentor slides and Audio Files can be found under their name below.
8:00 - 8:15 am Welcome and Opening Remarks
Marie McCormick, M.D., ScD, Committee Chair
Audio
8:15 - 8:30 Congressional Speakers
Congressman Dave Weldon, U.S. House of Representatives
Submitted Remarks
Audio
8:30 – 9:30 Etiologic factors and pathogenesis of autism: evidence from
clinical studies and animal models
Mady Hornig, M.D., Associate Professor, Columbia University
Mailman School of Public Health
Slides Unavailable
Audio
Q & A
9:30 – 10:00 Association of Autistic Spectrum Disorder and MMR Vaccine:
A Systematic Reviewof Current Epidemiological Evidence
Kumanan Wilson, M.D., MSc, Division of Clinical Decision Making
and Health Care, Toronto General Research Institute, Canada
Slides
Audio
Q & A
10:00 - 10:30 Age at First Measles-Mumps-Rubella Vaccination in Children
with Autism and School-Matched Control Subjects
Frank DeStefano, MD, Centers for Disease Control and Prevention
Slides
Audio
Q & A
10:30 -10:45 Break
10:45 – 11:15 Exposure to Thimerosal-Containing Vaccines in UK Children
and Autism
Dr. Elizabeth Miller, Head, Immunisation Division, Public Health
Laboratory Service, Communicable Disease Surveillance Centre,
London, UK
Slides
Audio
Q & A
11:15 – 11:45 Vaccine Safety Datalink Study: Autism Outcome
Robert L. Davis, M.D., M.P.H., University of Washington Group
Health, Cooperative Depts. of Pediatrics Center for Health Studies
and Epidemiology
Slides
Audio
Q & A
11:45 – 12:15 Study of the Association Between Thimerosal-Containing Vaccine
and Autism in Denmark
Anders Peter Hviid, MSc, Department of Epidemiology Research,
State Serum Institute, Copenhagen, Denmark
Slides
Audio
Q & A
12:15 – 12:45 Autism and thimerosal-containing vaccines: analysis of the Vaccine
Adverse Events Reporting System (VAERS)
Mark R. Geier, M.D., Ph.D., President, The Genetic Centers
of America
David Geier, President of MedCon
Slides
Audio
Q & A
12:45 – 1:45 Lunch
1:45 - 2:15 A Toxicologist's View of Thimerosal and Autism
H. Vasken Aposhian, Ph.D., Professor, Molecular and Cellular
Biology, University of Arizona
Slides
Audio
Q & A
2:15– 2:45 Relation of Neurotoxic Effects of Thimerosal to Autism
David Baskin, M.D., Professor of Neurosurgery and Anesthesiology,
Baylor College of Medicine
Slides Unavailable
Audio
Q & A
2:45 – 3:15 Thimerosal Exposure From Vaccines and Ethylmercury Accumulation
in Non-human Primates
Dr. Polly Sager, Assistant Director for International Research, National
Institute of Allergy and Infectious Diseases
Slides (This PowerPoint presentation was corrected by Dr. Sager on
May 3, 2004. Slides 20-23 were in error, and now reflect the
correct information)
Audio
Q & A
3:15 – 3:30 Break
3:30 – 4:00 Reduced Levels of Mercury in First Baby Haircuts of Autistic Children
Boyd Haley, Ph.D., Chairman and Professor, Department of Chemistry,
University of Kentucky
Slides
Audio
Q & A
4:00 – 4:30 A Case-control Study of Mercury Burden in Children with Autistic
Disorders and Measles Virus Genomic RNA in Cerebrospinal Fluid
in Children with Regressive Autism
Jeff Bradstreet, M.D., FAAFP, Adjunct Professor, Neurosciences,
Stetson University, Director of Clinical Programs, International Child
Development Resource Center, Florida
Slides
Audio
Q & A
4:30 – 5:00 Autism, Vaccines, and Immune Reactions
Vijendra K. Singh, Ph.D., Research Associate Professor, Utah
State University
Slides Unavailable
Audio
Q & A
5:00 – 5:30 Public Comment Period
Audio
5:30 pm Adjourn
Page last updated March 8, 2004
|